Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 14Prostatic Neoplasms 13Brain Neoplasms 12Sarcoma 7Meningioma 6Pancreatic Neoplasms 5Lung Neoplasms 5Glioma 5Esophageal Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Glioblastoma 4Carcinoma, Hepatocellular 4Breast Neoplasms 4Solid Tumor, Adult 3Rhabdomyosarcoma 3Head and Neck Neoplasms 3Chondrosarcoma 3Uterine Cervical Neoplasms 2Thymus Neoplasms 2Radiation Injuries 2Pituitary Neoplasms 2Pinealoma 2Osteosarcoma 2Oligodendroglioma 2Nerve Sheath Neoplasms 2Neoplasms 2Nasopharyngeal Carcinoma 2Liver Neoplasms 2Hodgkin Disease 2Gliosarcoma 2

Interventions

Fluorouracil 267Oxaliplatin 266Capecitabine 224Leucovorin 209Irinotecan 151Radiotherapy 131Bevacizumab 112Cetuximab 81Folfox protocol 48Surgical Procedures, Operative 44Radiation 41Drug Therapy 41Neoadjuvant Therapy 40Chemoradiotherapy 33Chemotherapy, Adjuvant 32Panitumumab 27XELOX 25Magnetic Resonance Spectroscopy 22Radiotherapy, Intensity-Modulated 21Floxuridine 17Biopsy 16Nivolumab 15Gemcitabine 15Early Intervention, Educational 15pembrolizumab 14Laparoscopy 14IFL protocol 14Celecoxib 14trifluridine tipiracil drug combination 13Gene Expression Profiling 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Rectal Neoplasms × Proton Therapy × Clear all
NCT00503932 2012-03-22

Proton Therapy With Capecitabine for Rectal Cancer

M.D. Anderson Cancer Center

Phase 1/2 Withdrawn
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡